Prevention of autoimmune diabetes in the DRBB rat by CD40/154 blockade

Journal of Autoimmunity

Volumn 19, Issue 3, 2002, Pages 139-145

  Moore, Wayne V ^a   Chu, Wenjiang ^a   Tong, Pei Y ^a   Hess, Donna ^b   Benjamin, Christopher ^b   Khalili, Jahan ^a   Kover, Karen ^a  

^a CHILDREN S MERCY HOSPITAL   (United States)

^b BIOGEN   (United States)

Author keywords

Autoimmune diabetes; CD40 154 blockade; Prevention

Indexed keywords

CD40 ANTIGEN; CD40 LIGAND; CD40 LIGAND MONOCLONAL ANTIBODY; ANTIBODY;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN ANTIBODY COMPLEX; ARTICLE; AUTOIMMUNE DISEASE; CONTROLLED STUDY; DIABETES MELLITUS; DOSE RESPONSE; DRUG ACTIVITY; DRUG MECHANISM; HISTOPATHOLOGY; INFLAMMATION; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; RAT; RAT STRAIN; T LYMPHOCYTE; ANIMAL; IMMUNOLOGY; INSULIN DEPENDENT DIABETES MELLITUS; INTRAVENOUS DRUG ADMINISTRATION; PANCREAS ISLET; PATHOLOGY;

ANIMALS; ANTIBODIES; ANTIGENS, CD40; CD40 LIGAND; DIABETES MELLITUS, TYPE 1; INJECTIONS, INTRAVENOUS; ISLETS OF LANGERHANS; RATS;

EID: 0036850826     PISSN: 08968411     EISSN: None     Source Type: Journal    
DOI: 10.1006/jaut.2002.0605     Document Type: Article

References (24)

1. 1996. Type 1 Diabetes: Molecular, Cellular, and Clinical Immunology G.S. Eisenbarth, K.J. Lafferty, eds. Oxford University Press, Inc., Cary, NC
2. Van Kooten C., Banchereau J. 1997. Immune regulation by CD40-CD40L interactions. Frontiers in Bioscience 12: 1-11
3. Grewal IS., Flavell R.A. 1998. CD40 and CD154 in cell-mediated immunity. Annu. Rev. Immunol. 16: 111-135
4. Sayegh M.H., Turka L.A. 1995. T cell costimulatory pathways: Promising novel targets for immunosuppression and tolerance induction. J. Am. Soc. Nephrol. 6: 1143-1150
5. Markees T.G., Serreze D.V., Phillips N.E., Sorli C.H., Gordon E.J., Shultz L.D., Noelle R.J., Woda B.A., Greiner D.L., Mordes J.P., Rossini A.A. 1999. NOD mice have a gerneralized defect in their response to transplantation tolerance induction. Diabetes 48: 967-974
6. Molano E.D., Berney T., Li H., Cattan P., Pileggi A., Vizzardelli C., Kenyon N.S., Ricordi C., Burkly L.C., Inverardi L. 2001. Prolonged islet graft survival in NOD mice by blockade of the CD40-CD154 pathway of T-cell costimulation. Diabetes 50: 270-276
7. Leiter E. 1998. Genetics and immunogenetics of NOD mice and related strains. In NOD Mice and Related Strains: Research Applications In Diabetes, AIDS, Cancer, And Other Diseases E. Leiter, M. Atkinson, eds. RG Landes, Austin, TX, pp. 37-69
8. Bowman M.A., Leiter E.H., Atkinson M.A. 1994. Prevention of diabetes in NOD mouse: Implications for therapeutic intervention in human disease. Immunol. Today 15: 115-120
9. Kover K.L., Geng Z., Hess D.M., Benjamin C.D., Moore W.V. 2000. Anti-CD154 (CD40L) prevents recurrence of diabetes in islet isografts in the DR-BB rat. Diabetes 49: 1666-1670
10. Kover K.L., Geng Z., Hess D.M., Benjamin C.D., Moore W.V. 2001. CD40/154 blockade and rejection of islet allografts in the streptozotocin and autoimmune diabetic rat. Pediatric Diabetes 2: 178-183
11. Mordes J.P., Bortell R., Groen H., Guberski D., Rossini A.A., Greiner D.L. Autoimmune Diabetes Mellitus in the BB Rat.
12. Morikawa M., Tamatani T., Miyasaka M., Uede T. 1994. Cardiac allografts in rat recipients with simultaneous use of anti-ICAM1 and anti-LFA1 monoclonal antibodies leads to accelerated graft loss. Immunopharmacology 28: 171-182
13. Azuma H., Chandraker A., Nadeau K., Hancock W.W., Carpenter CB., Tilney N., Sayegh MH. 1996. Blockade of T cell costimulation prevents development of experimental chronic renal allograft rejection. Proc. Natl. Acad. Sci. USA 93: 12439-12444
14. Sayegh M.H., Turka L.A. 1995. T cell costimulatory pathways: Promising novel targets for immunosuppression and tolerance induction. J. Am. Soc. Nephrol. 6: 1143-1150
15. Lenschow DJ., Ho S.C., Scatter H., Rhee L., Gray G., Nabavi N., Herold K.C., Bluestone J.A. 1995. Differential effects of anti-B7-1 and anti-BBB7-2 monoclonal antibody treatment on the development of diabetes in the nonobese diabetic mouse. J. Exp. Med. 181: 1145-1155
16. Alegre M.I., Lenschow D.J., Bluestone J.A. 1995. Immunomodulation of transplant rejection using monoclonal antibodies and soluble receptors. Dig. Dis. Sci. 40: 58-64
17. Hollenbaugh D., Grosmaire L.S., Kullas C.D., Chalupny N.J., Braesch-Andersen S., Noelle RJ., Stamenkovic I., Ledbetter J.A., Aruffo A. 1992. The human T cell antigen gp39, a member of the TNF gene family, is a ligand for the CD40 receptor: Expression of a soluble form of gp39 with B cell costimulatory activity. EMBO J. 11: 4313-4321
18. Krummel M.F., Sullivan T.J., Allison J.P. 1995. Superantigen responses and co-stimulation: CD28 and CTLA-4 have opposing effects on T cell expansion in vitro and in vivo. Internat. Immunol. 8: 519-523
19. Luhder R., Hoglund P., Allison J.P., Benoist C., Mathis D. 1998. Cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) regulates the unfolding of autoimmune diabetes. J. Exp. Med. 187: 427-432
20. Chambers C.A., Kuhns M.S., Allison J.P. 1999. Cytotoxic T lymphocyte antigen-4 (CTLA-4) regulates primary and secondary peptide-specific CD4+ T cell responses. Proc. Natl. Acad. Sci. USA 96: 8603-8608
21. Hoglund P., Mintern J., Waltzinger C., Heath W., Benoist C., Mathis D. 1999. Initiation of autoimmune diabetes by developmentally regulated presentation of islet cell antigen in the pancreatic lymphnodes. J. Exp. Med. 189: 331-339
22. Andre-Schmutz I., Hindelang C., Benoist C., Mathis D. 1999. Cellular and molecular changes accompanying the progression from insulitis to diabetes. Eur. J. Immunol. 29: 245-255
23. Howard L.M., Miga A.J., Vanderlugt C.L., Dal Canto M.C., Laman J.D., Noelle R.J., Miller S.C. 1999. Mechanisms of immunotherapeutic intervention by anti-CD40L (CD154) antibody in an animal model of multiple sclerosis. J. Clin. Invest. 103: 281-290
24. Balasa B., Krahl T., Patstone G., Lee J., Tisch R., McDevitt H.O., Sarvetnick N. 1997. CD40 ligand-CD40 interactions are necessary for the initiation of insulitis and diabetes in nonobese diabetic mice. J. Immunol. 159: 4620-4627